Tomomi Egawa-Takata1, Ruriko Nakae2,3, Mariko Shindo4, Ai Miyoshi5, Tsuyoshi Takiuchi2, Takashi Miyatake1, Tadashi Kimura2. 1. Department of Obstetrics and Gynecology, Osaka Police Hospital , Osaka, Japan. 2. Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine , Suita, Japan. 3. Department of Obstetrics and Gynecology, Sumitomo Hospital , Osaka, Japan. 4. Department of Obstetrics and Gynecology, Hannan Central Hospital , Matsubara, Japan. 5. Department of Obstetrics and Gynecology, Kaizuka City Hospital , Kaizuka, Japan.
Abstract
INTRODUCTION: The HPV vaccination rate in Japan has been dismally low. Our previous survey work found that mothers in Japan, who have a strong influence over their daughters, often are receptive to the fathers' participation in the family's decision-making process about getting their daughter HPV vaccinated. METHODS: We conducted a survey to investigate the nature of the influence of fathers' participation on the mother's decision-making process. From an internet survey panel, we selected a pool of 1,499 eligible mothers who had 12-18 years old daughters. The mothers were randomized into three Groups. To the mothers in Group A, we gave an educational leaflet regarding HPV vaccination and a second leaflet which recommended that they talk with their husbands about the vaccination. To Group B, we gave only the educational leaflet. No leaflets were sent to Group C. A structured survey questionnaire was then distributed through the internet to the mothers. RESULTS: In Groups A, B, and C, their intention to have their daughter receive the HPV vaccine was 21.6%, 20.7% and 8.2%, respectively. The percent of Group A mothers who thought their husband's opinion was important for when they made the decision was significantly higher (70%) than in Group B (56.6%) or Group C (47.1%). CONCLUSIONS: The fathers' participation in the mothers' decision-making does not increase the likelihood of HPV vaccination for their daughters. On the other hand, the educational leaflet proved to be effective for this cause.
INTRODUCTION: The HPV vaccination rate in Japan has been dismally low. Our previous survey work found that mothers in Japan, who have a strong influence over their daughters, often are receptive to the fathers' participation in the family's decision-making process about getting their daughter HPV vaccinated. METHODS: We conducted a survey to investigate the nature of the influence of fathers' participation on the mother's decision-making process. From an internet survey panel, we selected a pool of 1,499 eligible mothers who had 12-18 years old daughters. The mothers were randomized into three Groups. To the mothers in Group A, we gave an educational leaflet regarding HPV vaccination and a second leaflet which recommended that they talk with their husbands about the vaccination. To Group B, we gave only the educational leaflet. No leaflets were sent to Group C. A structured survey questionnaire was then distributed through the internet to the mothers. RESULTS: In Groups A, B, and C, their intention to have their daughter receive the HPV vaccine was 21.6%, 20.7% and 8.2%, respectively. The percent of Group A mothers who thought their husband's opinion was important for when they made the decision was significantly higher (70%) than in Group B (56.6%) or Group C (47.1%). CONCLUSIONS: The fathers' participation in the mothers' decision-making does not increase the likelihood of HPV vaccination for their daughters. On the other hand, the educational leaflet proved to be effective for this cause.
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702
Authors: Berit Feiring; Ida Laake; Tor Molden; Inger Cappelen; Siri E Håberg; Per Magnus; Ólöf Anna Steingrímsdóttir; Bjørn Heine Strand; Jeanette Stålcrantz; Lill Trogstad Journal: BMJ Open Date: 2015-05-19 Impact factor: 2.692
Authors: Eva Herweijer; Karin Sundström; Alexander Ploner; Ingrid Uhnoo; Pär Sparén; Lisen Arnheim-Dahlström Journal: Int J Cancer Date: 2016-03-09 Impact factor: 7.396